Pilot Study of IGF-Methotrexate Conjugate in the Treatment of Myelodysplastic Syndrome, CMML and Oligoblastic AML

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT03175978

Title field or adapter rule

protocolSection.identificationModule.officialTitle

Ingested At

2026-04-25T22:26:31.329901+00:00

Published At

2024-05-21T00:00:00+00:00

Record Updated At

2024-05-21

Results Posted At

2024-05-21

Timestamp Basis

source retrieval time was not retained by the feed adapter

Date limitation

source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Myelodysplastic Syndromes", "Leukemia, Myelomonocytic, Chronic", "Anemia, Refractory, With Excess of Blasts"]

protocolSection.statusModule.lastUpdatePostDateStruct.date

"2024-05-21"

protocolSection.identificationModule.nctId

"NCT03175978"

protocolSection.identificationModule.officialTitle

"Pilot Study of IGF-Methotrexate Conjugate in the Treatment of Myelodysplastic Syndrome, CMML and Oligoblastic AML"

protocolSection.statusModule.overallStatus

"TERMINATED"

protocolSection.designModule.phases

["PHASE1", "PHASE2"]

protocolSection.statusModule.resultsFirstPostDateStruct.date

"2024-05-21"

Study condition terms

• Myelodysplastic Syndromes (protocolSection.conditionsModule.conditions)
• Leukemia, Myelomonocytic, Chronic (protocolSection.conditionsModule.conditions)
• Anemia, Refractory, With Excess of Blasts (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.